We are live on ! Find out more
MIRO

Miromatrix Medical Inc. Common Stock
MIRO

Delisted

MIRO was delisted on the 12th of December, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Miromatrix Medical Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 32 → 0 (-32)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $8.78M → $0 (-$8.78M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 32

Holders
–
Holders Change
-32
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
-$2.99M
2
GS
Gagnon Securities
New York
-$1.91M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$863K
4
GA
Gagnon Advisors
New York
-$729K
5
RI
RTW Investments
New York
-$583K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLAM
1
First Light Asset Management
Minnesota
– -$2.99M -2,278,670 Closed
GS
2
Gagnon Securities
New York
– -$1.91M -1,458,351 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$863K -658,548 Closed
GA
4
Gagnon Advisors
New York
– -$729K -556,755 Closed
RI
5
RTW Investments
New York
– -$583K -445,222 Closed
MC
6
Mayo Clinic
Minnesota
– -$251K -191,622 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$210K -173,776 Closed
GIPM
8
G2 Investment Partners Management
New York
– -$221K -168,723 Closed
SFP
9
Sweet Financial Partners
Minnesota
– -$183K -139,553 Closed
PCM
10
Perkins Capital Management
Minnesota
– -$156K -119,320 Closed
LWAM
11
Legacy Wealth Asset Management
Minnesota
– -$120K -91,701 Closed
RJA
12
Raymond James & Associates
Florida
– -$84.2K -64,300 Closed
MFG
13
Merit Financial Group
Georgia
– -$77.2K -58,900 Closed
BlackRock
14
BlackRock
New York
– -$73.4K -56,042 Closed
HWM
15
HighMark Wealth Management
Minnesota
– -$68.1K -51,972 Closed
Envestnet Asset Management
16
Envestnet Asset Management
Illinois
– -$62.9K -48,036 Closed
State Street
17
State Street
Massachusetts
– -$36.3K -30,017 Closed
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
– -$35K -26,669 Closed
TWM
19
Tradition Wealth Management
Minnesota
– -$31K -23,900 Closed
Northern Trust
20
Northern Trust
Illinois
– -$31K -23,699 Closed
WVP
21
Worth Venture Partners
New Jersey
– -$28.4K -23,509 Closed
Charles Schwab
22
Charles Schwab
California
– -$13.4K -11,036 Closed
US Bancorp
23
US Bancorp
Minnesota
– -$13.1K -10,000 Closed
TRCT
24
Tower Research Capital (TRC)
New York
– -$7.06K -5,388 Closed
HWA
25
HHM Wealth Advisors
Tennessee
– -$4.58K -3,500 Closed
1
2

MIRO Hedge Fund Activity: Q4 2023 in Review

0 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q4 2023, worth a combined $0 — down 100% from $8.78M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of MIRO and 0 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was First Light Asset Management, exiting entirely with an estimated $2.99M sold.

  • 0 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q4 2023, down from 32 in Q3 2023.
  • Funds reported $0 of Miromatrix Medical Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Miromatrix Medical Inc. Common Stock positions in Q4 2023 and 32 closed out, a net change of -32 holders.
  • The largest Miromatrix Medical Inc. Common Stock seller in Q4 2023 was First Light Asset Management, an estimated $2.99M sold.

Based on aggregated 13F filings for Q4 2023.